Pages that link to "Q71093213"

The following pages link to Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis (Q71093213):

Displaying 32 items.

• Cystic Fibrosis Adult Care (Q22306058) (← links)
• Inhaled corticosteroids for cystic fibrosis (Q24193120) (← links)
• Inhaled corticosteroids for cystic fibrosis (Q24202923) (← links)
• Inhaled corticosteroids for cystic fibrosis (Q24241634) (← links)
• Cystic fibrosis (Q28350599) (← links)
• The role of inhaled corticosteroids in the management of cystic fibrosis (Q34131911) (← links)
• Use of modulators of airways inflammation in patients with CF. (Q34773482) (← links)
• The role of inflammation in the pathophysiology of CF lung disease (Q34773499) (← links)
• Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis (Q35012421) (← links)
• Ginseng treatment reduces bacterial load and lung pathology in chronic Pseudomonas aeruginosa pneumonia in rats (Q35135835) (← links)
• Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis (Q35256369) (← links)
• Inhaled fluticasone in bronchiectasis: a 12 month study (Q35537562) (← links)
• Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis (Q35557791) (← links)
• Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects. (Q36342592) (← links)
• Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? (Q36815073) (← links)
• International practice patterns by age and severity of lung disease in cystic fibrosis: Data from the epidemiologic registry of cystic fibrosis (ERCF) (Q36882061) (← links)
• Anti-inflammatory therapies for cystic fibrosis-related lung disease (Q37188760) (← links)
• The Cystic Fibrosis Neutrophil: A Specialized Yet Potentially Defective Cell (Q37839809) (← links)
• Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line (Q40521090) (← links)
• Anti-inflammatory effects of montelukast in mild cystic fibrosis. (Q44252555) (← links)
• Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis (Q44577526) (← links)
• Anti-inflammatory therapy in cystic fibrosis (Q44690839) (← links)
• Management of pulmonary involvement in mucoviscidosis in the child (Q44999792) (← links)
• Complementary therapies in cystic fibrosis: evidence of therapeutic benefits and treatment recommendations (Q50324932) (← links)
• Cystic fibrosis (Q56084190) (← links)
• Normativa del diagnóstico y el tratamiento de la afección respiratoria en la fibrosis quística (Q61479586) (← links)
• Cystic Fibrosis: From Qualification to Lung Transplantation, a Single Center Experience (Q64070195) (← links)
• New prospects in cystic fibrosis treatment (Q73657825) (← links)
• Basic therapies in cystic fibrosis. Does standard therapy work? (Q77366690) (← links)
• Therapies aimed at airway inflammation in cystic fibrosis (Q77366694) (← links)
• [Mucoviscidosis: therapeutic strategies are multiplying] (Q77681664) (← links)
• Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients? (Q79787712) (← links)